Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

BioNTech SE (BNTX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow BioNTech's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
183.11 +2.67    +1.48%
05/08 - Closed. Currency in USD ( Disclaimer )
After Hours
188.21
+5.10
+2.79%
19:59:51 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,579,757
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 177.63 - 185.09
BioNTech 183.11 +2.67 +1.48%
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2022
31/03
2021
31/12
2021
30/09
2021
30/06
Total Current Assets 19466.1 15072.3 13551.4 8439.5
Cash and Short Term Investments 6165 2074.3 2394.5 914.9
Cash 6164.1 1692.7 2392.7 914.1
Cash & Equivalents - 1692.7 2392.7 914.1
Short Term Investments 0.9 381.6 1.8 0.8
Total Receivables, Net 12696.2 12382.1 10604.8 7052.6
Accounts Receivables - Trade, Net 12695.8 12381.7 10603.9 7051.7
Total Inventory 459.3 502.5 393.4 305.4
Prepaid Expenses - - - -
Other Current Assets, Total 145.6 113.4 158.7 166.6
Total Assets 20299.6 15830.8 14232.6 9148.8
Property/Plant/Equipment, Total - Net 556.9 520.4 442.1 381.1
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net 216 202.4 162.9 164.1
Long Term Investments 48.4 21.3 - -
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 12.2 14.4 76.2 164.1
Other Assets, Total - - - -
Total Current Liabilities 3854.5 3481.6 4902.6 3163.3
Accounts Payable 123.7 160 258.9 262.7
Payable/Accrued - - - -
Accrued Expenses - - - -
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 30.6 129.9 19 13.9
Other Current liabilities, Total 3700.2 3191.7 4624.7 2886.7
Total Liabilities 4388.9 3937.1 5521.1 3666
Total Long Term Debt 155.4 171.6 267.7 242.9
Long Term Debt 155.4 171.6 267.7 242.9
Capital Lease Obligations - - - -
Deferred Income Tax 50.9 66.7 - -
Minority Interest - - - -
Other Liabilities, Total 328.1 217.2 350.8 259.8
Total Equity 15910.7 11893.7 8711.5 5482.8
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 246.8 246.3 246.3 246.3
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) 15667.7 11651.2 8469 5240.3
Treasury Stock - Common -3.8 -3.8 -3.8 -3.8
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - - - -
Total Liabilities & Shareholders' Equity 20299.6 15830.8 14232.6 9148.8
Total Common Shares Outstanding 242.52 242.52 241.52 241.52
Total Preferred Shares Outstanding - - - -
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BNTX Comments

Write your thoughts about BioNTech SE
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Sylvia Doloff
Sylvia Doloff Aug 05, 2022 12:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
can someone elaborate on why bntx is up today nicely while moderna and nocanax are significantly negative
ranma kaitani
ranma kaitani Aug 05, 2022 12:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Maybe because they are optimistic about Biontech earnings / financial reports for Monday (8 August)  Especially when they saw Moderna's good earnings.
Sylvia Doloff
Sylvia Doloff Aug 05, 2022 11:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ok looks like bntx could be worth holding for a little bit how do you feel about the three vaccine stocks
Sylvia Doloff
Sylvia Doloff Jul 27, 2022 1:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
crazy I got in and got out four days ago along with moderna novanax was a big loss
Sylvia Doloff
Sylvia Doloff Jul 22, 2022 2:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
here is why it is tanking because I bought 25 shares I am the kiss of death
lee doloff
lee doloff Jul 11, 2022 4:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It looks like the world is about to dive further into turmoil with a new wave of covid coupled with recession and panic
lee doloff
lee doloff Jul 11, 2022 4:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think the vaccine stocks could be the only way to go
gowtham kotha
gowtham kotha Jun 20, 2022 4:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No direction yet
Rob Roo
Rob Roo May 23, 2022 2:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
🚀🔆Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose.
Alp Gunaydin
Alp Gunaydin May 10, 2022 5:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Covid is done, just like this stock. No movea will occur Until they produce something from their pipeline
Alper Drn
Alper Drn May 10, 2022 5:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Coming soon I believe..
Rob Roo
Rob Roo Apr 28, 2022 12:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
🚀 Great entry point for Therapeutics ready to release from the huge pipeline!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email